Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Punwani

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Anesthesiology Clinics|October 4, 2013
The evolution of checklists and implications for anesthesiologyFred E Shapiro, Rebecca L Grammer, Nathan Punwani, et al.
Anesthesia and Analgesia|July 22, 2014
Office-based anesthesia: safety and outcomesFred E Shapiro, Nathan Punwani, Noah M Rosenberg, et al.
Leukemia Research Reports|March 21, 2018
Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemiaNathan Punwani, Noah Merin, Ann Mohrbacher, et al.
Haematologica|July 9, 2026
Characteristics of clonal cytopenia of undetermined significance in the presence of <i>ZRSR2</i> mutationsMahmoud Yacout, Bahga Katamesh, Yazan Jabban, et al.
Haematologica|January 8, 2026
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in <i>TP53</i>-mutated myelodysplastic syndromesMahmood Aldapt, Yu-Hung Wang, Kashish J Shah, et al.
Blood Cancer Journal|October 6, 2025
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patientsAli Alsugair, Estefania Gauto Mariotti, Mohammad M Alhousani, et al.
Blood Cancer Journal|April 6, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patientsSaubia Fathima, Lior Rokach, Nour Ghosoun, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Anesthesiology Clinics|October 4, 2013
The evolution of checklists and implications for anesthesiologyFred E Shapiro, Rebecca L Grammer, Nathan Punwani, et al.
Anesthesia and Analgesia|July 22, 2014
Office-based anesthesia: safety and outcomesFred E Shapiro, Nathan Punwani, Noah M Rosenberg, et al.
Leukemia Research Reports|March 21, 2018
Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemiaNathan Punwani, Noah Merin, Ann Mohrbacher, et al.
Haematologica|July 9, 2026
Characteristics of clonal cytopenia of undetermined significance in the presence of <i>ZRSR2</i> mutationsMahmoud Yacout, Bahga Katamesh, Yazan Jabban, et al.
Haematologica|January 8, 2026
Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in <i>TP53</i>-mutated myelodysplastic syndromesMahmood Aldapt, Yu-Hung Wang, Kashish J Shah, et al.
Blood Cancer Journal|October 6, 2025
Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patientsAli Alsugair, Estefania Gauto Mariotti, Mohammad M Alhousani, et al.
Blood Cancer Journal|April 6, 2026
CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patientsSaubia Fathima, Lior Rokach, Nour Ghosoun, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Pageof 2